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Breastfeeding-associated inﬂammatory breast diseases appear especially during the ﬁrst twelve weeks postpartum and are the
most common reason for early cessation of breastfeeding. It also becomes increasingly evident that these inﬂammatory mammary
diseases are triggered or perpetuated in a large part by psychosocial stress. Immunological processes taking place during this
cascade in the mammary gland and consequences for the breastfeed newborn are mostly yet unknown. This review summarizes
insights from studies on modulation of cytokine levels in breast milk during inﬂammatory processes like milk stasis and mastitis
systematically. It also gives an overview on possible pathological eﬀects, which these cytokine changes in the breast milk might
have on the newborn.
Copyright © 2008 Achim W¨ ockel et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
1.1. Milkstasisandmastitis
The WHO suggests a six-month period of breastfeeding to
all breastfeeding mothers [1]. Evidence-based advantages for
mother and child result especially when children in this
time are fed exclusively without any additional breast milk
supplements [2]. Only 50% of women worldwide reach this
goal [3]. The remaining mothers very often add supplements
or cease breastfeeding completely because they suﬀer from
inﬂammatory breast diseases like milk stasis or puerperal
mastitis [4].
These breastfeeding-associated inﬂammatory breast dis-
eases appear especially during the ﬁrst twelve weeks postpar-
tum and are the most common reason for an early cessation
of breastfeeding [5]. Changes develop like a cascade [4–
6]: ﬁrst little erosions caused by the suckling of the infant
lead to severe nipple and areolar pain. Pain anticipates
an undisturbed breastfeeding relationship and leads to an
insuﬃcient emptying of the breast by the newborn. An
insuﬃcient emptying of the breast can subsequently lead to
a stasis in the mammary alveoli. This milk stasis augments
pain and opens intercellular junctions between the milk
duct epithelial cells caused by a rise of intraductal pressure.
Breast milk, then moving into the connective tissue, leads
to a primary a sterile inﬂammation, generally followed by a
secondary bacterial infection. In the worst cases, this results
in a puerperal mammary abscess, which has to be surgically
treated.
Immune mediators such as cell subsets or cytokines
involved in this perpetuating inﬂammation in the mammary
gland in humans are mostly unknown.
In veterinary medicine, a number of scientists work on
the subject focussing on bovine mastitis in experimental
studies, since bovine mastitis causes enormous economic
damage in the dairy industry [7], and hence, the dairy
industry has a vast interest in the development of analytical
methods to identify animals at risk when symptoms are
still inapparent. The goal of these research endeavors is
to identify early risk markers, that is in milk or maternal
serum. In this context, the somatic cell count (SCC/mL),
bacterial count (colony-forming units [CFUs]/mL), ratio
of milk phagocytes (mononuclear [Mphi] plus polymor-
phonuclear [PMN] cells) to lymphocytes (P/L index), and
ratio of PMN to Mphi cells (PMN/Mphi index) and also2 Mediators of Inﬂammation
the measurement of cytokines in milk could be used to
identiﬁcate the inﬂammatory reactions in the mammary
tissue [8]. Immunomodulating agents are also normally
present in human milk in physiologically relevant quantities
but there is a wide range of concentrations of diﬀerent
cytokines at each time during the ﬁrst 12 weeks of lactation:
IL-1: 15-400pg/mL; IL-6: 15-1032pg/mL; TNF-alpha: 15-
2933pg/mL; Prostaglandin E2: 10-9966pg/mL; TGF-beta1:
43-7108pg/mL; TGF-beta2: 208-57935pg/mL [9].
1.2. Diseasesofthebreastduringlactationandstress
It is generally believed that inﬂammatory breastfeeding-
associatedmammarydiseasesmaybetriggeredoraggravated
by psychosocial stress, as observed for example in veterinary
medicine. Here, exposure to experimental stressors such as
regrouping and relocation resulted into mastitis in animals,
as described for lactating ewes [10]. In humans, clini-
cal observations reveal similar correlations: mothers with
breastfeeding-associated diseases (milk stasis and mastitis)
report an increased stress perception, that is due to events
in their social network in the weeks prior to the clinical
symptoms [11]. Recent studies performed by the authors
further support the alleged causality of stress perception and
puerperal diseases in humans [12].
What are the possible pathophysiological mechanisms
of stress-dependent breast diseases during lactation? The
increased secretion of catecholamines in stressed mothers
impairs the release and access of oxytocin to the mammary
gland and the action of oxytocin on the secretory epithelium
[13]. The release of oxytocin in response to stressful stimuli
may reduce the availibility of this hormone at the suckling
reﬂex. Stress also leads to higher levels of prolactine and thus
to an increased synthesis of breast milk. The reduced release
or impaired action of oxytocin and the coexistent higher
proposal of breast milk cause an incomplete emptying of the
alveoli and galactophorus ducts and lead to milk stasis.
Stressfull events may also cause immune supression
in the mammary tissue. T-lymphocytes have regulatory
functions or act directly on foreign antigens because of
producing cytokines. T-lymphocytes are strongly involved in
the defense against bacterial invasion during mastitis [14].
These cells are uniquely sensitive to soluble modulating
factors, so it is likely that the neuroendocrine response in
stress elaborates hormones and peptides that may have a
major impact on cell mediated immunity [15]. The increase
in maternal stress perception has recently been shown to
cause a priming of the maternal immune system towards a
proinﬂammatory, Th1-cytokine response (IL-1, IL-6, TNF-
a, INF-y) instead of anti-inﬂammatory Th2-cytokines (IL-4,
IL-5, IL-9 and IL-13) in the mammary tissue [12].
At birth the immune system of the neonate is primed
towards a Th2 dominance. Within the ﬁrst 2 years of life, the
immune system is activated, probably via childhood infec-
tions, leading to a naturally occurring shift from Th2 to Th1
immunity. Intestinal mucosa is also premature in the ﬁrst
two years. Thus higher concentrations of proinﬂammatory
Th-1-cytokines in the breast milk may lead to local and
systemic immunological eﬀects of the newborn [16].
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Figure 1: Vicious cycle of increased maternal stress perception,
inﬂammatory breast diseases, and diseases of the newborn trans-
mitted by changes in the cytokine pattern in breast milk.
1.3. Modiﬁedcytokinepatternsofthebreastmilkand
theireffectsonthechild
Maternal stress perception is likely intimately linked to
stress reactions of the newborn. Published data indicate
that the oﬀspring may develop somatic diseases [17], well
described for atopic dermatitis, bronchitis, and allergic
diseases in response to maternal stress perception [16, 18].
Most of these studies focus on imprinting such as maternal
stress perception programming the child in utero, which is
generally referred to as the fetal programming hypothesis.
Surprisingly,todate,theperiodoflactationhasreceivedvery
littleattentioninthiscontext.Here,ithasbeendescribedthat
a long period of lactation minimizes the risk for infection of
the oﬀspring due to high levels of IgA in breast milk, which
may protect the oﬀspring from infectious diseases [19].
However,itstillremainstobeelucidatedifandhowmaternal
stress perception aﬀects immune markers in the breast milk
and whether such alterations may have consequences for
the child’s well being. Given the yet unexplained dramatic
increase of chronic inﬂammatory diseases in children over
the past 5 decades [20], the identiﬁcation of a vicious cycle
between stress perception, impaired breastfeeding/nutrition
of the oﬀspring and the onset of chronic diseases is urgently
required and it is the aim of the present review to foster
future research in this direction.
If a major part of breast diseases, as proven in our
own surveys, is caused by stress and at the same time the
prevalence of these diseases is relatively high [12], a change
in the constituents of breast milk would be imaginable.
One possibility is a change in the cytokine proﬁle in
breast milk, which then might lead to diseases in the child
(Figure 1). Further, recent studies predominately arising
from rodents have elegantly shown that the epigenome
of the developing fetus is sensitive to maternal nutrition,
exposure to environmental toxins as well as to psychological
stress [21]. It is postulated that exposure of the young pup
to social behavior, such as maternal care, could aﬀect the
epigenome. Epigenetic alterations, which could have similar
consequencesasgeneticpolymorphisms,havebeenshownto
arise from variations of maternal behavior and may accountAchim W¨ ockel et al. 3
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Figure 2: Flow-chart describing the process of selection and
identiﬁcation of literature.
for diﬀerences in human behavior and possibly vulnerability
to diseases later in life of the oﬀspring. Hence, impaired
breastfeeding could aﬀect the growing oﬀspring in a number
of ways, that is via an altered immune cocktail in the breast
milk. But also impaired maternal caring behavior due to
discontinuation of breastfeeding may lead to eﬀects on the
psychological development and thus on the immune system
of the newborn, because breastfeeding seems to be also very
important for emotional bonding [22].
The aim of this systematic review was to show detectable
changes of cytokines in breast milk during inﬂammatory
processes of mammary tissue like mastitis and possible
pathological eﬀects of these mediators on the newborn
caused by breastfeeding.
2. METHODOLOGY OF THE PRESENT REVIEW
In order to identify published evidence addressing the
topics (1) cytokines detectable in inﬂammatory processes
like a mastitis in breast milk and (2) pathological eﬀects
of cytokines in the breast milk on the newborn, literature
databases (Medline, Embase) were searched. The following
search strategies were developed to identify the publications
most sensitively. Search strategy 1: (“mastitis” [MeSH Terms]
OR mastitis [Text Word]) AND (“human milk” [Text Word]
OR“milk,human”[MeSHTerms]OR“milk”[MeSHTerms]
OR milk [Text Word]) AND (“cytokines” [MeSH Terms]
OR cytokines [Text Word]); search strategy 2: (“cytokines”
[MeSH Terms] OR cytokines [Text Word]) AND (“lacta-
tion” [MeSH Terms]) OR (“breast feeding” [TIAB] NOT
Medline [SB]) OR “breast feeding” [MeSH Terms] OR
LACTATION [Text Word]) AND (“newborn infant” [Text
Word] OR “infant, newborn” [MeSH Terms] OR newborn
[Text Word]). All articles published in German or English
between 2002 until 2007 were included. This period was
established to get the most current results of this ﬁeld of
research. Veterinary and human studies, experimental and
clinical surveys were analysed. An overview on the process
of research and selection is shown in Figure 2.
3. RESULTS
Searching according to the above-described key word strat-
egy yielded a total of 191 publications (titles or abstracts):
afterselectionoftheliterature,16publicationsremained(see
Figure 2), 10 of which referred to the ﬁrst topic, 6 focussing
on the second topic. 175 of the publications addressed none
of the two topics of interest and were excluded: most of these
experimental or observation-studies described changes of
cytokines in blood (and not in breast milk) during mastitis,
which was not the focus of this review.
Results from the ﬁrst search strategy are presented in
Table 1. All identiﬁed studies [23–32] describe an increase
of predominately proinﬂammatory cytokines in milk or
peripheral leukocytes in response to experimental challenge
set by artiﬁcial infection with diﬀerent germs. Stress percep-
tion has not been included in the design of these studies.
Results from the second search strategy are presented
in Table 2. Here, we identiﬁed 5 cohort studies [33–37]
where cytokine levels in breast milk were linked to diﬀerent
alterations or diseases in the oﬀspring. During revision and
selection of the literature, we also identiﬁed one further
publication [38], which especially examined the inﬂuence of
cytokine-patternsontheincidenceofallergiesinthechild.In
this publication, a correlation between these variables could
not be established. Thus, a change of cytokines in breast milk
may not have an inﬂuence on the incidence or progression of
allergies.
4. CONCLUDING REMARKS
An increase of cytokines in breast milk has been reported
from diﬀerent stages of maternal lactation: on the one hand,
maternal diseases during pregnancy—like pre-eclampsia or
allergies—can lead to a rise in cytokines of breast milk
[39]. In addition, the systematic review of the literature
performed here showed a modulation of cytokine levels
in breast milk during inﬂammatory chest diseases during
lactation. As there are mostly only animal studies available,
it has to be investigated in humans if and to which extent
levels of cytokines are modulated in breast milk. In addition,
this review revealed that an imbalance of cytokines in breast
milk may have severe consequences for the child, which in
turn aﬀects the child’s development. However, the studies
summarized here with regard to the two topics focussed
on diﬀerent cytokines and in diﬀerent species. Future work
is needed to clear if and how these observations can be
translated into clinical signiﬁcance. Further, none of these
studies included stress perception as a possible trigger for
cytokine imbalances in the breast milk. Nonetheless, it
still remains to be elucidated how stress perception may
trigger inﬂammatory events of the breast. Further, one
may easily envision that mastitis and the related impaired
breastfeeding ability itself are potent stressors, which may
additionally aggravate the clinical symptoms. Thus, research
endeavours should focus on the identiﬁcation of markers,
preferably immune markers, prior to the onset of clinical
symptoms. To date, the relationship between stress and
mastitis is supported by own observations [12]a n dw i l l4 Mediators of Inﬂammation
Table 1: Key ﬁndings on immune alteration in breast milk, identiﬁed upon search for the topic “cytokines detectable in inﬂammatory
processes like a mastitis in breast milk.”
Publication Animal study Human study Key ﬁnding
Dernfalk et al. [23]+
The quantiﬁcation of enhanced proinﬂammatory cytokines IL-1beta, IL-6, and
TNF-α in bovine whey or milk samples is indicative for an acute inﬂammatory
response of mammary tissue.
Bannerman et al. [24]+
Persistingly increased levels of TGF-α, -ß1, and -ß2 in milk were evident upon
infection with S. aureus.
Lee et al. [25]+
Inﬂammatory cytokines (interleukin (IL)-6, IL-8, IL-12, granulocyte
macrophage-colony stimulating factor (GM-CSF), tumor necrosis factor TNF-α,
and interferon (IFN)-γ, secreted by somatic cells present in the breast milk) were
characterized by real-time polymerase chain reaction (PCR) in dairy cows upon
experimental challenged with either E. coli or S. aureus.
Bannerman et al. [26]+
Systemic and localized bovine innate immune responses to intramammary
infection with P. aeruginosa were characterized and increased levels of IL-8,
TNF-α, IL-10, and IL-12 were detected. Elevation of these cytokines was not
sustained for longer than a 24-hour period.
Chockalingam et al. [27]+
Analysis of whey samples derived from E. coli-infected quarters revealed an
increase of TGF-α, -ß1, and -ß2.
Rambeaud et al. [28]+
S. uberis challenge induced local production of TNF-α, IL-1ß, and IL-8 in
mammary tissue.
Alluwaimi et al. [29]+
Transcriptional activity of bovine cytokines IL-12 and TNF-α levels was
signiﬁcantly elevated upon experimental S. aureus infection. Levels of IL-2 were
decreased. IL-12 and TNF-α levels were signiﬁcantly elevated at 24 hours
post-infectionem (pi) followed by sharp decrease at 32 hours pi.
Persson Waller et al. [30]+
Intramammary infusion of endotoxin from E. coli in cows resulted in neutrophil
increase in aﬀerent and eﬀerent supramammary lymph nodes. Concentrations
of IL-8 increased in lymph nodes. TNF-α levels increase in lymph nodes and
milk. The levels of IL-1ß increased in milk, but were not detected in lymph
nodes. Interferon-γ was undetectable.
Riollet et al. [31]+
IL-1α,I L - 1 ß ,I L - 6a n dT N F - α, IL-10, and IL-12 mRNA were synthesized in cells
derived from infected mammary glands, whereas neither IL-2 nor IL-4 mRNA
could be detected.
Prgomet et al. [32]+
Cell culture models were established, where milk somatic cells and peripheral
leukocytes were cultured and activated with lipopolysaccharide (LPS). Via real
time RT-PCR, increased cytokine mRNA levels could be detected for TNF-α,
IL-6, and IL-1ß, which persisted longer in peripheral leukocytes compared to
milk somatic cells.
have to be conﬁrmed in larger collectives. However, it is
nowadays well accepted that high stress perception can alter
immune hemostasis and render the individual, both adults
and newborn, less resistant to infectious diseases. It has been
suggestedthatthisisduetoincreasedlevelsofcorticosteroids
which can eﬀect the functions, pattern, and numbers of
leucocytes and thus increase the hostc ¸s susceptibility to
infections [40].
What are possible pathophysiological mechanisms for
the shown increase of interleukines in breast milk during
inﬂammatory processes? The proportion of T cells in
mammary tissue normally declines during lactation and
the number of T cell subsets (CD4, CD8, and WC1-T
cells in ruminants) varies signiﬁcantly during this period.
The proportions of several cell populations (CD2, CD4,
CD8, MCHC II) are lower in milk than in blood following
parturition, while the proportion of WC1+ cells is higher in
milk [40]. But an increase of plasma cortisol (i.e., caused by
stress) has been shown to decrease the number of circulating
lymphocytes. The number of T cells in blood declines
after the rise of serumcortisol, but expression of adhesion
molecules on these cells is not aﬀected. This suggests that
glucocorticoids can enhance migration of T cells from blood
intomammarytissues[41].Thismightbeimportanttoavert
inﬂammatory reactions and to perpetuate the secretion of
cytokines in the gland and the breast milk.
What kind of biological mechanism could be made
responsible for that? So on the one hand, a rise in cytokines
of breast milk is useful to activate a mechanism of maternal
self-defence against infectious processes in the glandular
tissue [42]. On the other hand, a rise in cytokines in
breast milk could be useful in breastfed infants in order
to activate or stimulate their immunity [43]. It is possible
though that a permanent oversupply of cytokines (i.e.,
triggered by high maternal stress perception) leads to an
excessive stimulation/threat of the child immune system andAchim W¨ ockel et al. 5
Table 2: Key ﬁndings on immune alteration in breast milk, identiﬁed upon search for the topic “pathological eﬀects of cytokines in the
breast milk on the newborn.”
Publication Animal study Human study Key ﬁnding
Zanardo et al. [33]+
Levels of IL-1ß are signiﬁcantly increased in colostrum from breast-feeding
mothers whose infants have hyperbilirubineamia.
Moore et al. [34]+
Levels of IL-7 in breast-milk, sensitive to seasonal inﬂuences, may mediate
thymus function of the newborn.
Prokeˇ sov´ ae ta l .[ 35]+
Allergic mothers exhibit markedly higher IL-10 levels in breast milk compared to
healthy mothers.
Rigotti et al. [36]+ Lower levels of TGF-ß1 are present in mature milk of allergic mothers.
Bryan et al. [37]+
Breast milk from mothers of infants hospitalized with bronchiolitis had
signiﬁcantly higher levels of IL-2 and IL-10 compared with milk from mothers of
postpartum age-matched healthy controls.
B¨ ottcher et al. [38]+
There was no association between levels of IL-4, -5, -6, -8, -10, -13, -16, IFN-γ,
TGF-ß1, -ß2, in the breast milk of mothers whose infants developed allergic
symptoms or salivary IgA levels during the ﬁrst 2 years of life. Thus, diﬀerences
in the composition of cytokines and chemokines in breast milk did not, to any
major degree, aﬀect the development of atopic symptoms nor salivary IgA
antibody production during the ﬁrst 2 years of life.
subsequently to the onset of diseases. This hypothesis is
supported by results by Elmlinger et al. [44] and Ustundag
et al. [45] who showed that breast milk from mothers
who delivered preterm children contained lower levels of
cytokines compared to breast milk from mothers of term
children. The proposal of cytokines in maternal breast milk
seems to adapt to the requirement of the newborn and
acts in accordance with development status of the immune
system. Probably the immune system of the newborn is
fragile for disruptive factors also like changes of cytokine-
concentrations mediated my breastfeeding.
The review shows evidence of increased cytokines in
breast milk during inﬂammatory processes like mastitis
and possible pathological eﬀects of these higher cytokine-
concentrations on the newborn. A correlation between these
consequences on state of health and special interleukins in
breast milk could not be detected in the current literature
and should be investigated in further studies.
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